+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Over The Counter (OTC) Testing - Global Market Trajectory & Analytics

  • ID: 5303623
  • Report
  • April 2021
  • Region: Global
  • 183 pages
  • Global Industry Analysts, Inc
1 of 2
Global Over The Counter (OTC) Testing Market to Reach $27 Billion by 2027

Amid the COVID-19 crisis, the global market for Over The Counter (OTC) Testing estimated at US$14.2 Billion in the year 2020, is projected to reach a revised size of US$27 Billion by 2027, growing at a CAGR of 9.6% over the analysis period 2020-2027. Glucose Monitoring Tests, one of the segments analyzed in the report, is projected to record a 9.5% CAGR and reach US$8.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Pregnancy & Fertility Tests segment is readjusted to a revised 10.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $4.2 Billion, While China is Forecast to Grow at 9% CAGR

The Over The Counter (OTC) Testing market in the U.S. is estimated at US$4.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.7 Billion by the year 2027 trailing a CAGR of 9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 7.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.

Infectious Disease Tests Segment to Record 10.8% CAGR

In the global Infectious Disease Tests segment, USA, Canada, Japan, China and Europe will drive the 10.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.9 Billion in the year 2020 will reach a projected size of US$3.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.1 Billion by the year 2027.

Select Competitors (Total 33 Featured):
  • Abbott Laboratories
  • AccuBioTech
  • ACON Laboratories
  • bioLytical Laboratories
  • i-Health Lab
  • LabStyle Innovations
  • NOWDiagnostics Company
  • OraSure Technologies
  • Roche Diagnostics
  • SD Biosensor
  • Sinocare
Note: Product cover images may vary from those shown
2 of 2
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Over The Counter (OTC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Over The Counter (OTC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Over The Counter (OTC) Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • Table 4: World Current & Future Analysis for Glucose Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Glucose Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Glucose Monitoring Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 7: World Current & Future Analysis for Pregnancy & Fertility Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Pregnancy & Fertility Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Pregnancy & Fertility Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 10: World Current & Future Analysis for Infectious Disease Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Infectious Disease Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Infectious Disease Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 13: World Current & Future Analysis for Coagulation Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Coagulation Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for Coagulation Monitoring Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 16: World Current & Future Analysis for Urinalysis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 17: World Historic Review for Urinalysis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 18: World 15-Year Perspective for Urinalysis Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 19: World Current & Future Analysis for Cholesterol Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 20: World Historic Review for Cholesterol Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 21: World 15-Year Perspective for Cholesterol Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 22: World Current & Future Analysis for Drugs-of-Abuse Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 23: World Historic Review for Drugs-of-Abuse Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 24: World 15-Year Perspective for Drugs-of-Abuse Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 25: World Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 26: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 27: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 28: World Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 29: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 30: World 15-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 31: World Current & Future Analysis for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 32: World Historic Review for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 33: World 15-Year Perspective for Dipsticks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 34: World Current & Future Analysis for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 35: World Historic Review for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 36: World 15-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
  • UNITED STATES
  • Table 37: USA Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 38: USA Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 39: USA 15-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2012, 2020 & 2027
  • Table 40: USA Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 41: USA Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 42: USA 15-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2012, 2020 & 2027
  • CANADA
  • Table 43: Canada Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 44: Canada Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 45: Canada 15-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2012, 2020 & 2027
  • Table 46: Canada Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 47: Canada Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 48: Canada 15-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2012, 2020 & 2027
  • JAPAN
  • Table 49: Japan Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 50: Japan Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 51: Japan 15-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2012, 2020 & 2027
  • Table 52: Japan Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 53: Japan Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 54: Japan 15-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2012, 2020 & 2027
  • CHINA
  • Table 55: China Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 56: China Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 57: China 15-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2012, 2020 & 2027
  • Table 58: China Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 59: China Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 60: China 15-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2012, 2020 & 2027
  • EUROPE
  • Table 61: Europe Current & Future Analysis for Over The Counter (OTC) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 62: Europe Historic Review for Over The Counter (OTC) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 63: Europe 15-Year Perspective for Over The Counter (OTC) Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • Table 64: Europe Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 65: Europe Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 66: Europe 15-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2012, 2020 & 2027
  • Table 67: Europe Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 68: Europe Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 69: Europe 15-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2012, 2020 & 2027
  • FRANCE
  • Table 70: France Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 71: France Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 72: France 15-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2012, 2020 & 2027
  • Table 73: France Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 74: France Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 75: France 15-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2012, 2020 & 2027
  • GERMANY
  • Table 76: Germany Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 77: Germany Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 78: Germany 15-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2012, 2020 & 2027
  • Table 79: Germany Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 80: Germany Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 81: Germany 15-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2012, 2020 & 2027
  • ITALY
  • Table 82: Italy Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 83: Italy Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 84: Italy 15-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2012, 2020 & 2027
  • Table 85: Italy Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 86: Italy Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 87: Italy 15-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
  • Table 88: UK Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 89: UK Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 90: UK 15-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2012, 2020 & 2027
  • Table 91: UK Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 92: UK Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 93: UK 15-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2012, 2020 & 2027
  • REST OF EUROPE
  • Table 94: Rest of Europe Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 95: Rest of Europe Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 96: Rest of Europe 15-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2012, 2020 & 2027
  • Table 97: Rest of Europe Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 98: Rest of Europe Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 99: Rest of Europe 15-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
  • Table 100: Asia-Pacific Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 101: Asia-Pacific Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 102: Asia-Pacific 15-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2012, 2020 & 2027
  • Table 103: Asia-Pacific Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 104: Asia-Pacific Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 105: Asia-Pacific 15-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2012, 2020 & 2027
  • REST OF WORLD
  • Table 106: Rest of World Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 107: Rest of World Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 108: Rest of World 15-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2012, 2020 & 2027
  • Table 109: Rest of World Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 110: Rest of World Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 111: Rest of World 15-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2012, 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 33
Note: Product cover images may vary from those shown
Adroll
adroll